-The Indian Express On agriculture, three years into the Modi government, while many steps have been taken to realise promises made in 2014, others have fallen by the wayside With the Modi government completing three years in office, it is time to assess its performance in various sectors. We focus here on agriculture. Without robust growth in agriculture, “sabka saath, sabka vikas” will remain an empty slogan. There are two ways to evaluate...

-PTI New Delhi: NGOs whose licences were suspended for non-compliance of government rules have been given a final deadline of 14 June to file their returns for the last five years. They would have to upload their annual returns for the financial years 2010-11 to 2014-15 along with a renewal application under the mandatory Foreign Contribution (Regulation) Act, a home ministry spokesperson said on Tuesday. The government is estimated to have cancelled the...

-The Hindu The discourse must move beyond a top-down approach to listen to the people and formulate best insurance practices Much ink has been spilled in documenting the inadequacy of budgetary allocations for public health insurance, specifically for the Rashtriya Swasthya Bima Yojana (RSBY), the world’s largest publicly-funded health insurance (PFHI) scheme. Though the 2017-18 budget allocation has marginally increased from last year’s revised estimates, it has declined relative to last year’s...

-The Hindu PoS devices’ demand falls on remonetisation, user charges Cash transactions are beginning to trump almost every form of digital payment alternative with April clocking a decline in volumes as well as value of transactions conducted through cards, mobile banking and the Unified Payment Interface (UPI). The trend assumes significance six months after the Centre announced demonetisation of ?500 and ?1,000 notes on November 8. The near-completion of the remonetisation process and merchants...

-The Times of India Multinational stent companies claim that the ceiling price fixed by the National Pharmaceutical Pricing Authority (NPPA) is commercially unviable, but they are selling at far lower prices in much richer countries with smaller markets than India such as Germany, the UK, Italy and many other European countries. A look at the prices of stent brands in these countries shows that people in India have been defrauded of crores...